- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Prostate Carcinoma in New Zealand
Total 5786 results
-
Alessa Therapeutics Inc.CompletedLower Urinary Tract Symptoms | Prostate AdenocarcinomaUnited States, Australia, New Zealand
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Inspirna, Inc.RecruitingLung Cancer | Endometrial Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Carcinoma | Endometrial Cancer Recurrent | Lung Cancer RecurrentUnited States
-
Precision Biopsy, Inc.UnknownCellular Diagnosis, Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Salivary Gland Carcinoma | Stage IVA Major Salivary Gland Cancer AJCC v7 | Stage IVB Major Salivary Gland Cancer AJCC v7 | Stage IVC Major Salivary Gland Cancer AJCC v7 | Tongue Carcinoma | Salivary Gland Adenoid Cystic Carcinoma | Recurrent Oral Cavity Adenoid Cystic Carcinoma | Stage... and other conditionsUnited States, Canada
-
Albert Einstein College of MedicineNational Cancer Institute (NCI); Eli Lilly and Company; OSI PharmaceuticalsCompletedStage IIIB Non-Small Cell Lung Cancer | Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Bronchioloalveolar Carcinoma | Large Cell Lung CarcinomaUnited States
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
KangLaiTe USATerminated
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Stage IV Fallopian Tube Cancer AJCC v6 and v7 | Stage IV Ovarian Cancer AJCC v6 and v7 | Stage IV Primary Peritoneal Cancer AJCC v7 | Ovarian High Grade Serous Adenocarcinoma | Platinum-Sensitive... and other conditionsUnited States
-
ProteoMediX AGCompletedIndication for Prostate Biopsy Due to Suspected Prostate CancerAustria, Germany, Denmark
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Rhabdoid Tumor | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Rhabdoid Tumor | Refractory Rhabdoid Tumor | Epithelioid Sarcoma | Kidney Medullary Carcinoma | Atypical Teratoid/Rhabdoid Tumor | Poorly Differentiated Chordoma | Recurrent Atypical... and other conditionsUnited States, Canada, Australia
-
National Cancer Institute (NCI)Active, not recruitingCirrhosis | Hepatitis B Infection | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm | Recurrent Hepatocellular Carcinoma | Refractory Malignant Neoplasm | Hepatitis C Infection | Stage IV Hepatocellular Carcinoma AJCC v7United States
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
Precision Biopsy, Inc.UnknownCellular Diagnosis, Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Primary Peritoneal Cancer | Recurrent Ovarian Cancer | Fallopian TubeUnited States
-
BeiGeneTerminatedMetastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)United States, Australia, Puerto Rico, Spain
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingRecurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Endometrial Serous Adenocarcinoma | Recurrent Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell... and other conditionsUnited States, Canada
-
Johnson & Johnson Private LimitedWithdrawn
-
Roswell Park Cancer InstituteTerminated
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma | Stage IV Prostate AdenocarcinomaUnited States, Canada
-
Maimonides Medical CenterCompleted
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Terminated
-
New Mexico Cancer Care AllianceTerminatedProstate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma | Stage IVB Cervical CancerUnited States, Spain
-
Memorial Sloan Kettering Cancer CenterCompletedMRI | Prostate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Thyroid Gland Carcinoma | Poorly Differentiated Thyroid Gland Carcinoma | Refractory Thyroid Gland Carcinoma | Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 | Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IVA Thyroid... and other conditionsUnited States
-
PDS Biotechnology Corp.Merck Sharp & Dohme LLCActive, not recruitingHPV Positive Oropharyngeal Squamous Cell Carcinoma | Recurrent Head and Neck Cancer | Metastatic Head and Neck Cancer | Neoplasms, Head and NeckUnited States, Puerto Rico, Ireland, United Kingdom
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; Stand Up To CancerActive, not recruitingMetastatic Prostate CancerUnited States
-
Carolina Research Professionals, LLCBayerUnknownProstate Cancer MetastaticUnited States
-
Opna-IO LLCTerminatedMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
Yale UniversityCompleted
-
NYU Langone HealthTerminatedProstate CancerUnited States
-
New Mexico Cancer Care AllianceTerminatedProstate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteCompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
New York Prostate InstituteSanofiUnknownProstate CancerUnited States
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingProstate CarcinomaUnited States
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Ruhr University of BochumCompletedRecurrent Ovarian CancerGermany
-
Merrion Pharmaceuticals, LLCCompletedHormone-Refractory Prostate CancerUnited States, Estonia, Latvia
-
AstraZenecaCompletedMetastatic Castration-resistant Prostates CancerIndia, Peru, Saudi Arabia, Egypt, Colombia, Korea, Republic of, Turkey, United Arab Emirates
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
University of California, San DiegoNYU Langone Health; American Urogynecologic SocietyCompletedRecurrent Urinary Tract InfectionUnited States
-
DisperSol Technologies, LLCTranslational Drug DevelopmentActive, not recruiting